title: Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice.
abstract: To investigate the role of apoM in high density lipoprotein (HDL) metabolism and atherogenesis, we generated human apoM transgenic (apoM-Tg) and apoM-deficient (apoM(-/-)) mice. Plasma apoM was predominantly associated with 10-12-nm alpha-migrating HDL particles. Human apoM overexpression (11-fold) increased plasma cholesterol concentration by 13-22%, whereas apoM deficiency decreased it by 17-21%. The size and charge of apoA-I-containing HDL in plasma were not changed in apoM-Tg or apoM(-/-) mice. However, in plasma incubated at 37 degrees C, lecithin:cholesterol acyltransferase-dependent conversion of alpha- to pre-alpha-migrating HDL was delayed in apoM-Tg mice. Moreover, lecithin: cholesterol acyltransferase-independent generation of pre-beta-migrating apoA-I-containing particles in plasma was increased in apoM-Tg mice (4.2 +/- 1.1%, p = 0.06) and decreased in apoM(-/-) mice (0.5 +/- 0.3%, p = 0.03) versus controls (1.8 +/- 0.05%). In the setting of low density lipoprotein receptor deficiency, apoM-Tg mice with approximately 2-fold increased plasma apoM concentrations developed smaller atherosclerotic lesions than controls. The effect of apoM on atherosclerosis may be facilitated by enzymatic modulation of plasma HDL particles, increased cholesterol efflux from foam cells, and an antioxidative effect of apoM-containing HDL.
authors.affiliation: Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark. Christina.christoffersen@rh.regionh.dk.
authors.forename: Christina
authors.initials: C
authors.lastname: Christoffersen
authors.forename: Matti
authors.initials: M
authors.lastname: Jauhiainen
authors.forename: Markus
authors.initials: M
authors.lastname: Moser
authors.forename: Bo
authors.initials: B
authors.lastname: Porse
authors.forename: Christian
authors.initials: C
authors.lastname: Ehnholm
authors.forename: Michael
authors.initials: M
authors.lastname: Boesl
authors.forename: Björn
authors.initials: B
authors.lastname: Dahlbäck
authors.forename: Lars Bo
authors.initials: LB
authors.lastname: Nielsen
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000737:chemistry / Q000378:metabolism; D016632:Apolipoprotein A-I / Q000097:blood / Q000737:chemistry / Q000235:genetics; D001053:Apolipoproteins / Q000097:blood* / Q000737:chemistry / Q000235:genetics; D000075243:Apolipoproteins M; D050197:Atherosclerosis / Q000097:blood* / Q000235:genetics; D002784:Cholesterol / Q000097:blood* / Q000235:genetics; D005487:Foam Cells / Q000378:metabolism; D015870:Gene Expression; D006801:Humans; D054834:Lipocalins; D008075:Lipoproteins, HDL / Q000097:blood* / Q000737:chemistry / Q000235:genetics; D051379:Mice; D018345:Mice, Knockout; D046912:Multiprotein Complexes / Q000097:blood* / Q000737:chemistry / Q000235:genetics; D007862:Phosphatidylcholine-Sterol O-Acyltransferase / Q000737:chemistry; D011973:Receptors, LDL / Q000235:genetics / Q000378:metabolism*
chemical_list: C400523:APOM protein, human; D000975:Antioxidants; D016632:Apolipoprotein A-I; D001053:Apolipoproteins; D000075243:Apolipoproteins M; D054834:Lipocalins; D008075:Lipoproteins, HDL; D046912:Multiprotein Complexes; D011973:Receptors, LDL; D002784:Cholesterol; D007862:Phosphatidylcholine-Sterol O-Acyltransferase